ClearPoint Neuro, Inc.: 10-Q filed 2016-11-09

Name: ClearPoint Neuro, Inc.: 10-Q filed 2016-11-09
Creator: ClearPoint Neuro, Inc.

What ClearPoint Neuro, Inc. reported in its quarterly report filed 2016-11-09 (fiscal Q3 2016): 28 published measures, 72 facts as tagged in accession 0001534424-16-001143.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-09
Fiscal period: fiscal Q3 2016
Accession: 0001534424-16-001143 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ClearPoint Neuro, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	9,014,355	USD
At 2015-12-31	9,936,722	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	8,439,770	USD
At 2015-12-31	11,917,861	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	574,585	USD
At 2015-12-31	-1,981,139	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	4,432,421	USD
At 2015-12-31	5,408,523	USD
At 2015-09-30	1,851,862	USD
At 2014-12-31	9,244,006	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-2,563,231	USD	92
2016-01-01 to 2016-09-30	-6,389,012	USD	274
2015-07-01 to 2015-09-30	-245,399	USD	92
2015-01-01 to 2015-09-30	-7,250,811	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	100,324	USD	274
2015-01-01 to 2015-09-30	72,021	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,616,333	USD	92
2016-01-01 to 2016-09-30	4,114,349	USD	274
2015-07-01 to 2015-09-30	1,246,434	USD	92
2015-01-01 to 2015-09-30	3,082,578	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-92,187,882	USD
At 2015-12-31	-85,726,580	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	430,705	USD
At 2015-12-31	440,606	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	238,101	USD	92
2016-01-01 to 2016-09-30	736,982	USD	274
2015-07-01 to 2015-09-30	268,880	USD	92
2015-01-01 to 2015-09-30	1,421,198	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-1,709,522	USD	92
2016-01-01 to 2016-09-30	-5,698,479	USD	274
2015-07-01 to 2015-09-30	-1,927,017	USD	92
2015-01-01 to 2015-09-30	-7,554,382	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	7,596,110	USD
At 2015-12-31	8,531,710	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	241,050	USD	92
2016-01-01 to 2016-09-30	843,983	USD	274
2015-07-01 to 2015-09-30	316,705	USD	92
2015-01-01 to 2015-09-30	936,043	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	3,392,080	USD
At 2015-12-31	7,653,202	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	1,510,827	USD
At 2015-12-31	697,807	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2016-09-30	803,537	USD
At 2015-12-31	1,218,043	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	4,756	USD	274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2016-09-30	1,802,178	USD
At 2015-12-31	1,807,895	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	1,886,220	USD	92
2016-01-01 to 2016-09-30	5,748,524	USD	274
2015-07-01 to 2015-09-30	2,132,777	USD	92
2015-01-01 to 2015-09-30	6,608,829	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	691,330	USD	92
2016-01-01 to 2016-09-30	2,098,465	USD	274
2015-07-01 to 2015-09-30	480,280	USD	92
2015-01-01 to 2015-09-30	1,434,723	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	3,610,524	shares
At 2015-12-31	2,284,537	shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2016-09-30	4,390,339	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-09-30	10,640	USD
At 2015-12-31	27,306	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	557,974	USD
At 2015-12-31	97,249	USD

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	125,076	USD	274
2015-01-01 to 2015-09-30	153,545	USD	273

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-4,877	USD	92
2016-01-01 to 2016-09-30	209,504	USD	274
2015-07-01 to 2015-09-30	45,302	USD	92
2015-01-01 to 2015-09-30	243,505	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-414,506	USD	274
2015-01-01 to 2015-09-30	368,492	USD	273

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	33,958	USD	274
2015-01-01 to 2015-09-30	-83,987	USD	273

Inspect the source

Entity: ClearPoint Neuro, Inc. / CIK 0001285550
Captured: 2026-09-20T07:49:10.325Z
SEC response SHA-256: 42cce1b4fae43ade1c2eab56e81afab6eae0d04e4ec290dc982d64b677ec31fb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001285550.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))